Juniper & Ivy Corp - 20 Feb 2019 Form 3 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
10%+ Owner
Signature
/s/ John W. Huemoeller II
Issuer symbol
AXIM
Transactions as of
20 Feb 2019
Net transactions value
$0
Form type
3
Filing time
23 Sep 2022, 16:05:37 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXIM Series C Preferred Stock 20 Feb 2019 Series C Preferred Stock $500,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person's sole shareholder is John W. Huemoeller, II, the Issuer's Chief Executive Officer and director. Reporting Person holds 500,000 shares of the Issuer's Series C Preferred Stock. Each share of the Issuer's Series C Preferred Stock is: (i) convertible into one (1) share of the Issuer's common stock; and (ii) for voting purposes, is entitled to vote 100 votes per share.